SOD1 and amyotrophic lateral sclerosis: A particularly influential study by Blacher et al. [40] demonstrated that certain gut microbes promote nicotinamide production, which in turn supports motor neuron health in SOD1-SOD1-G93A mice, which provided one of the first mechanistic links between gut microbiota and neuroprotection in ALS, highlighting microbial metabolites as potential therapeutic targets.